Old Web
English
Sign In
Acemap
>
Paper
>
P-152 The impact of 2nd-line treatment after 1st-line gemcitabine plus nab-paclitaxel in advanced pancreatic cancer patients
P-152 The impact of 2nd-line treatment after 1st-line gemcitabine plus nab-paclitaxel in advanced pancreatic cancer patients
2020
Maria Bensi
B. Di Stefano
Marta Chiaravalli
M. Ribelli
Alexia Spring
Maria Grazia Maratta
Cinzia Bagalà
Giampaolo Tortora
Lisa Salvatore
Keywords:
Gemcitabine
Medicine
Oncology
Pathology
Pancreatic cancer
Internal medicine
Nab-paclitaxel
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]